CCC
Cilo Cybin Holdings Limited cultivates, manufactures, and sells medical cannabis products worldwide. The company offers CBD, THC, and THCV distillates; THC and CBD crude; CBD, CBG, and CBN isolates; CBD Nano Oil; oil in bottles, cannabis flower, and cannabis vapes; and topicals, capsules, and device products. It also provides flower sourcing, formulation, manufacturing, and primary and secondary … Read more
Market Cap & Net Worth: CCC (CCC)
CCC (JSE:CCC) has a market capitalization of $2.41 Billion (R45.86 Billion) as of March 18, 2026. Listed on the JSE stock exchange, this South Africa-based company holds position #24514 globally and #29 in its home market, demonstrating a 22.09% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CCC's stock price R199.00 by its total outstanding shares 230475136 (230.48 Million).
CCC Market Cap History: 2026 to 2026
CCC's market capitalization history from 2026 to 2026. Data shows growth from $2.41 Billion to $2.41 Billion (0.00% CAGR).
CCC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CCC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CCC by Market Capitalization
Companies near CCC in the global market cap rankings as of March 18, 2026.
Key companies related to CCC by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
CCC Historical Marketcap From 2026 to 2026
Between 2026 and today, CCC's market cap moved from $2.41 Billion to $ 2.41 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R2.41 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CCC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.41 Billion USD |
| MoneyControl | $2.41 Billion USD |
| MarketWatch | $2.41 Billion USD |
| marketcap.company | $2.41 Billion USD |
| Reuters | $2.41 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.